Five macrocyclic glycosides from Schoenoplectus tabernaemontani.

Nat Prod Res

a Xiangya School of Pharmaceutical Sciences, Central South University, Changsha , China.

Published: February 2019

Macrocyclic glycosides with unique 22-membered dimeric lactone skeleton, are rare occurring natural products. There are only ten compounds reported so far. Herein we reported the isolation and characterisation of five macrocyclic glycosides from Schoenoplectus tabernaemontani, including three new compounds (Schoenopolide A-C, 1-3) and two known ones, Berchemolide (4) and Clemoarmanoside B (5). Their structures were established on the basis of extensive analysis of spectroscopic data. In addition, the anti-oxidative activity of Berchemolide (4) against HO-induced of renal tubular epithelial (HK-2) cells was also evaluated.

Download full-text PDF

Source
http://dx.doi.org/10.1080/14786419.2018.1455195DOI Listing

Publication Analysis

Top Keywords

macrocyclic glycosides
12
glycosides schoenoplectus
8
schoenoplectus tabernaemontani
8
tabernaemontani macrocyclic
4
glycosides unique
4
unique 22-membered
4
22-membered dimeric
4
dimeric lactone
4
lactone skeleton
4
skeleton rare
4

Similar Publications

A Supramolecular Self-Assembled Nanoprodrug for Enhanced Ferroptosis Therapy.

ACS Nano

November 2024

Department of Chemical and Biomolecular Engineering, National University of Singapore, 4 Engineering Drive 4, 117585 Singapore.

Ferroptosis can induce cell death that leverages Fe-triggered Fenton reactions within living organisms, leading to an excessive accumulation of lipid peroxides (LPOs) and inducing cell death. Ferroptosis can effectively circumvent the inevitable drug resistance encountered with traditional apoptotic therapies. However, several issues remain in the clinical application of ferroptosis anticancer therapy, primarily due to the poor efficiency of intracellular Fenton reaction.

View Article and Find Full Text PDF

Here we report a macrocyclization route towards the synthesis of glycophane peptides by a selective C-H arylation of the anomeric bond. This approach demonstrates the power of Pd-catalysis C-H activation to access unusual cyclic peptides.

View Article and Find Full Text PDF

Technological advances and breakthrough developments in the pharmaceutical field are knocking at the door of the "undruggable" fortress with increasing insistence. Notably, the 21st century has seen the emergence of macrocyclic compounds, among which cyclic peptides are of particular interest. This new class of potential drug candidates occupies the vast chemical space between classic small-molecule drugs and larger protein-based therapeutics, such as antibodies.

View Article and Find Full Text PDF

The risk of inducing hypoglycaemia (low blood glucose) constitutes the main challenge associated with insulin therapy for diabetes. Insulin doses must be adjusted to ensure that blood glucose values are within the normal range, but matching insulin doses to fluctuating glucose levels is difficult because even a slightly higher insulin dose than needed can lead to a hypoglycaemic incidence, which can be anything from uncomfortable to life-threatening. It has therefore been a long-standing goal to engineer a glucose-sensitive insulin that can auto-adjust its bioactivity in a reversible manner according to ambient glucose levels to ultimately achieve better glycaemic control while lowering the risk of hypoglycaemia.

View Article and Find Full Text PDF
Article Synopsis
  • A supramolecular method was used to create nanoparticles by combining sodium carboxymethylcellulose and viologen calix[4]resorcinol in water at room temperature, driven by self-assembly.
  • The properties of the nanoparticles varied based on the ratio of polymer to macrocycle, with excess macrocycle enabling binding of oleic acid and excess polymer allowing for doxorubicin binding.
  • The nanoparticles showed enhanced solubilization of quercetin and better delivery into tumor cells compared to simpler compositions, paving the way for advancements in drug delivery systems.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!